1. Home
  2. ARWR vs OUT Comparison

ARWR vs OUT Comparison

Compare ARWR & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • OUT
  • Stock Information
  • Founded
  • ARWR 2003
  • OUT 2013
  • Country
  • ARWR United States
  • OUT United States
  • Employees
  • ARWR N/A
  • OUT N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • OUT Real Estate Investment Trusts
  • Sector
  • ARWR Health Care
  • OUT Real Estate
  • Exchange
  • ARWR Nasdaq
  • OUT Nasdaq
  • Market Cap
  • ARWR 2.4B
  • OUT 2.9B
  • IPO Year
  • ARWR 1993
  • OUT N/A
  • Fundamental
  • Price
  • ARWR $19.56
  • OUT $18.94
  • Analyst Decision
  • ARWR Buy
  • OUT Hold
  • Analyst Count
  • ARWR 11
  • OUT 6
  • Target Price
  • ARWR $43.33
  • OUT $19.00
  • AVG Volume (30 Days)
  • ARWR 1.5M
  • OUT 1.6M
  • Earning Date
  • ARWR 02-04-2025
  • OUT 02-19-2025
  • Dividend Yield
  • ARWR N/A
  • OUT 4.76%
  • EPS Growth
  • ARWR N/A
  • OUT N/A
  • EPS
  • ARWR N/A
  • OUT 1.41
  • Revenue
  • ARWR $3,551,000.00
  • OUT $1,838,900,000.00
  • Revenue This Year
  • ARWR $3,402.96
  • OUT N/A
  • Revenue Next Year
  • ARWR $123.96
  • OUT $1.95
  • P/E Ratio
  • ARWR N/A
  • OUT $13.40
  • Revenue Growth
  • ARWR N/A
  • OUT 1.37
  • 52 Week Low
  • ARWR $17.05
  • OUT $12.57
  • 52 Week High
  • ARWR $36.72
  • OUT $19.98
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 47.89
  • OUT 59.01
  • Support Level
  • ARWR $17.75
  • OUT $17.17
  • Resistance Level
  • ARWR $19.19
  • OUT $18.29
  • Average True Range (ATR)
  • ARWR 1.04
  • OUT 0.48
  • MACD
  • ARWR 0.04
  • OUT 0.08
  • Stochastic Oscillator
  • ARWR 59.74
  • OUT 83.48

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About OUT OUTFRONT Media Inc.

Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's major customers include entities within the retail, television, healthcare, and entertainment industries.

Share on Social Networks: